Pitavastatin is a modern statin for the correction of dyslipidemia and the risk of cardiovascular complications
Keywords:
Pitavastatin, modern statin, correction of dyslipidemia and the risk of cardiovascular complications, Resolution of the expert councilAbstract
Cardiovascular disease (CVD) is the leading cause of death worldwide, and coronary artery disease (CHD) is the main contributor to mortality from diseases of the circulatory system in developed countries. About 4 million people die from CVD in Europe every year, of whom the majority are women (2.2 million, 55%), although under the age of 65 CVD mortality is higher in men (490,000 versus 193,000)
Downloads
Download data is not yet available.
Downloads
Published
2017-06-29
How to Cite
Catapano A., Kukharchuk V. V., Sergienko I. V., Ezhov M. V., Susekov A. V., Gilyarevsky S. R., Martsevich S. Y., Chukaeva I. I. Pitavastatin is a modern statin for the correction of dyslipidemia and the risk of cardiovascular complications // The Journal of Atherosclerosis and Dyslipidemias. 2017. VOL. № 2 (27). PP. 104–107.
Issue
Section
Resolution